-
Product Insights
New![]()
Net Present Value Model: PolyPid Ltd’s Doxycycline hyclate CR
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. PolyPid Ltd's Doxycycline hyclate CR Drug Details: Doxycycline hyclate is under development for the prevention of post cardiac surgery sternal infections and post...
-
Product Insights
New![]()
Net Present Value Model: Soleno Therapeutics Inc’s Diazoxide choline CR
Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Mazindol CR in Opium (Opioid) Addiction
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Mazindol CR in Opium (Opioid) Addiction Drug Details: Mazindol is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Octreotide acetate CR in Acromegaly
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Octreotide acetate CR in Acromegaly Drug Details: Octreotide is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Diazoxide Choline Cr in Obesity
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diazoxide Choline Cr in Obesity Drug Details: Diazoxide choline controlled release (DCCR) is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride Cr in Diarrhea
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ondansetron Hydrochloride Cr in Diarrhea Drug Details:Ondansetron hydrochloride (RHB-102, Bekinda) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride Cr in Gastroenteritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Ondansetron Hydrochloride Cr in GastroenteritisDrug Details:Ondansetron hydrochloride (RHB-102, Bekinda) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride Cr in Gastritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Ondansetron Hydrochloride Cr in GastritisDrug Details:Ondansetron hydrochloride (RHB-102, Bekinda) is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CR-9114 in Influenzavirus A Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CR-9114 in Influenzavirus A InfectionsDrug Details:CR-9114 is under development for the protection against influenza A and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Rifamycin Sodium Cr in Diverticulitis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Rifamycin Sodium Cr in DiverticulitisDrug Details:Rifamycin sodium (Aemcolo, Relafalk) is an anti-infective agent. It is formulated...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Cilostazol CR in Intermittent Claudication
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Cilostazol CR in Intermittent Claudication Drug Details: Cilostazol CR (PMR) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CR-1301 in Intestinal Infection
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CR-1301 in Intestinal InfectionDrug Details:CR-1301 is under development for the treatment of chronic intestinal infections. It...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Nitazoxanide CR in Rhinovirus Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Nitazoxanide CR in Rhinovirus InfectionsDrug Details: Nitazoxanide is under development for the treatment of coronavirus disease...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Octreotide acetate CR in Neuroendocrine Tumors
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Octreotide acetate CR in Neuroendocrine Tumors Drug Details: Octreotide is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Rifamycin Sodium Cr in Hepatic Encephalopathy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Rifamycin Sodium Cr in Hepatic EncephalopathyDrug Details:Rifamycin sodium (Aemcolo, Relafalk) is an anti-infective agent. It is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CR-9114 in Influenzavirus B Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CR-9114 in Influenzavirus B InfectionsDrug Details:CR-9114 is under development for the protection against influenza A and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Doxycycline Hyclate Cr in Surgical Wound Infections
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDataÂ’s proprietary machine learning algorithms developed using over 10 years of historical data. Doxycycline Hyclate Cr in Surgical Wound Infections Drug Details: Doxycycline hyclate is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride Cr in Irritable Bowel Syndrome
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ondansetron Hydrochloride Cr in Irritable Bowel Syndrome Drug Details:Ondansetron hydrochloride (RHB-102, Bekinda) is under development for...
-
Product Insights
Bastian Qatar/ CR White Aurora – NorthPoint Development – Indiana
Equip yourself with the essential tools needed to make informed and profitable decisions with our Bastian Qatar/ CR White Aurora - NorthPoint Development - Indiana report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
DoT Florida – I-75 Interchange Improvements at CR 672 – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our DoT Florida - I-75 Interchange Improvements at CR 672 - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.